A minimally invasive, non-surgical treatment for benign thyroid nodules and recurrent thyroid cancer — performed under ultrasound guidance without general anesthesia.
Radiofrequency ablation (RFA) is a cutting-edge, office-based procedure that uses heat generated by high-frequency electrical current to shrink benign thyroid nodules, relieve compressive symptoms, and treat locally recurrent thyroid cancer. Dr. Guttler has been at the forefront of bringing RFA to the United States, training with world-leading experts in Italy and Korea.
RFA uses a thin electrode needle inserted into the thyroid nodule under real-time ultrasound guidance. Radiofrequency energy heats and destroys the nodule tissue from within, causing it to shrink over the following weeks and months. The surrounding thyroid tissue is preserved, and thyroid function typically remains normal.
RFA is ideal for patients with benign thyroid nodules confirmed by fine-needle aspiration (FNA) biopsy that are causing symptoms such as difficulty swallowing, a sensation of pressure in the neck, or cosmetic concerns. It is also used for autonomously functioning thyroid nodules causing hyperthyroidism, and for locally recurrent thyroid cancer in patients who are not surgical candidates.
Unlike thyroidectomy, RFA requires no general anesthesia, no incision, and no hospitalization. Patients return home the same day and resume normal activities within 24–48 hours. Thyroid hormone replacement is generally not needed because healthy thyroid tissue is preserved. The risk of damage to the recurrent laryngeal nerve or parathyroid glands — serious surgical complications — is essentially eliminated.
The procedure is performed in the office under local anesthesia. Using the 'moving-shot' technique, the electrode is repositioned continuously within the nodule to achieve uniform ablation. Most sessions last 20–45 minutes. Mild discomfort, warmth, or a brief ache in the neck is normal. Patients are monitored briefly and then discharged.
Studies show that RFA reduces nodule volume by 50–90% over 6–12 months. Compressive symptoms typically improve within weeks. Follow-up ultrasound is performed at 1, 3, 6, and 12 months. A small percentage of nodules may require a second treatment session. Long-term data from Korea and Europe confirm durable results with an excellent safety profile.
Dr. Guttler trained with Dr. Roberto Valcavi in Italy and Dr. Jung Hwan Baek in Korea — two of the world's foremost RFA pioneers. He has been instrumental in introducing and advocating for RFA in the United States, where it remains underutilized despite its proven track record. He offers RFA consultations for patients seeking a non-surgical alternative.
Thyroid Nodules: What You Need to Know
Most thyroid nodules are benign, but some require evaluation. Dr. Guttler explains ultrasound, biopsy, and when to consider RFA instead of surgery.
Lecture 4: Goiter & Benign Thyroid Nodules
Most thyroid nodules are benign. Dr. Guttler explains what causes goiters and nodules, how they are evaluated, and when treatment is needed.
Lecture 5: Thyroid Cancer — What Patients Need to Know
A thyroid cancer diagnosis is frightening — but thyroid cancer is among the most treatable of all cancers.